Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

440 public trials 56 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Active, Not Recruiting

A Study of Dato-DXd in Chinese Patients With Advanced Non-Small Cell Lung Cancer, Triple-negative Breast Cancer and Other Solid Tumors (TROPION-PanTumor02)

NCT05460273

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +13 more
Locations
  • Research Site Beijing, China
  • Research Site Beijing, China
  • Research Site Beijing, China
  • Research Site Bengbu, China
View all 21 locations
View Trial Details
Active, Not Recruiting

A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With Chemotherapy Compared With Pembrolizumab in Combination With Chemotherapy in Metastatic NSCLC Patients With Non-squamous Histology Who Have Mutations and/or Co-mutations in STK11, KEAP1, or KRAS

NCT06008093

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Research Site Beverly Hills, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Los Alamitos, California, United States
  • Research Site Los Angeles, California, United States
View all 47 locations
View Trial Details
Active, Not Recruiting

Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006)

NCT05298423

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • VA Long Beach Healthcare System ( Site 2831) Long Beach, California, United States
  • VA West Los Angeles Medical Center ( Site 2808) Los Angeles, California, United States
  • Millennium Oncology Research Clinic ( Site 2801) Hollywood, Florida, United States
  • Mid Florida Hematology and Oncology Center ( Site 2800) Orange City, Florida, United States
View all 160 locations
View Trial Details
Active, Not Recruiting

Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation

NCT05358249

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +25 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • NYU School of Medicine New York, United States
  • Novartis Investigative Site Leuven, Belgium
View all 13 locations
View Trial Details
Active, Not Recruiting

A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cancer

NCT05488314

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • University of Alabama at Birmingham, Comprehensive Cancer Center Birmingham, Alabama, United States
  • The Oncology Institute of Hope and Innovation Cerritos, California, United States
  • UCLA Los Angeles, California, United States
  • Montefiore Einstein Center for Cancer Care The Bronx, New York, United States
View all 78 locations
View Trial Details
Active, Not Recruiting

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

NCT04956640

Conditions
Adnexal Diseases, Biliary Tract Diseases, Biliary Tract Neoplasms, +36 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • USC Norris Cancer Hospital Los Angeles, California, United States
  • Chao Family Comprehensive Cancer Ctr. Orange, California, United States
  • Yale-New Haven Hospital New Haven, Connecticut, United States
View all 49 locations
View Trial Details
Active, Not Recruiting

A Study to Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lung Cancer (NSCLC) With and Without Central Nervous System (CNS) Metastases

NCT04603807

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Oncocentro Serviços Médicos e Hospitalares Ltda Fortaleza, Ceará, Brazil
  • Hospital Sao Rafael - HSR Salvador, Estado de Bahia, Brazil
  • Hospitais Integrados da Gavea S/A Brasília, Federal District, Brazil
  • Centro de Pesquisa e Ensino em Oncologia de Santa Catarina - CEPEN Florianópolis, Santa Catarina, Brazil
View all 61 locations
View Trial Details
Active, Not Recruiting

MYLUNG Consortium Study Protocol 2

NCT05644808

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Southern Cancer Center, PC Daphne, Alabama, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Woodlands Medical Specialists, PA Pensacola, Florida, United States
  • Illinois Cancer Specialists Niles, Illinois, United States
View all 18 locations
View Trial Details

Related conditions